top of page


mRNA therapies for treatment of Cystic Fibrosis
Photo Credit: Wix Cystic fibrosis is an autosomal recessive disorder, causes by mutations in the CFTR gene. It affects approx. 105,000 people worldwide. Before CFTR modulators were developed to treat cystic fibrosis, patients with CF rarely survived beyond their 20’s. With the advent of these transformative therapies patients with CF live well into their 60’s and 70’s. While CFTR modulators offer hope to 90% of the patients, many still are unable to benefit. About 10% of pati
Deepti Kumar
1 day ago2 min read


Friendly Fire Fighters: How CAR-MSCs Could Revolutionize Autoimmune Treatment
Millions Battling Their Bodies: A Global Rise in Autoimmune Diseases As reported earlier by MedReport Foundation, the global rise in...
MANISHA JALAN
Apr 30, 20242 min read
bottom of page

